JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M407627200 on October 7, 2004

J. Biol. Chem., Vol. 279, Issue 51, 53725-53735, December 17, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/51/53725    most recent
M407627200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J.
Right arrow Articles by Kim, S.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J.
Right arrow Articles by Kim, S.-Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Transglutaminase 2 Induces Nuclear Factor-{kappa}B Activation via a Novel Pathway in BV-2 Microglia*

Jongmin Lee{ddagger}§, Yoon-Seong Kim{ddagger}§, Dong-Hee Choi{ddagger}, Moon Suk Bang¶, Tai Ryoon Han¶, Tong H. Joh{ddagger}, and Soo-Youl Kim{ddagger}||

From the {ddagger}Department of Neurology and Neuroscience, Weill Medical College of Cornell University and Burke Medical Research Institute, White Plains, New York 10605 and Department of Rehabilitation Medicine, College of Medicine, Seoul National University, Seoul 110-744, Republic of Korea

Transglutaminase 2 (TGase 2) expression is increased in inflammatory diseases. We demonstrated previously that inhibitors of TGase 2 reduce nitric oxide (NO) generation in a lipopolysaccharide (LPS)-treated microglial cell line. However, the precise mechanism by which TGase 2 promotes inflammation remains unclear. We found that TGase 2 activates the transcriptional activator nuclear factor (NF)-{kappa}B and thereby enhances LPS-induced expression of inducible nitric-oxide synthase. TGase 2 activates NF-{kappa}B via a novel pathway. Rather than stimulating phosphorylation and degradation of the inhibitory subunit {alpha} of NF-{kappa}B (I-{kappa}B{alpha}), TGase2 induces its polymerization. This polymerization results in dissociation of NF-{kappa}B and its translocation to the nucleus, where it is capable of up-regulating a host of inflammatory genes, including inducible nitric-oxide synthase and tumor necrosis factor {alpha} (TNF-{alpha}). Indeed, TGase inhibitors prevent depletion of monomeric I-{kappa}B{alpha} in the cytosol of cells overexpressing TGase 2. In an LPS-induced rat brain injury model, TGase inhibitors significantly reduced TNF-{alpha} synthesis. The findings are consistent with a model in which LPS-induced NF-{kappa}B activation is the result of phosphorylation of I-{kappa}B{alpha} by I-{kappa}B kinase as well as I-{kappa}B{alpha} polymerization by TGase 2. Safe and stable TGase2 inhibitors may be effective agents in diseases associated with inflammation.


Received for publication, July 7, 2004 , and in revised form, October 4, 2004.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Both authors contributed equally to this work.

|| To whom correspondence should be addressed. Tel.: 914-597-2500, ext. 3041; Fax: 914-597-2757; E-mail: tgase{at}hanmail.net.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
J. Y. Hwang, L. S. Mangala, J. Y. Fok, Y. G. Lin, W. M. Merritt, W. A. Spannuth, A. M. Nick, D. J. Fiterman, P. E. Vivas-Mejia, M. T. Deavers, et al.
Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma
Cancer Res., July 15, 2008; 68(14): 5849 - 5858.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Falasca, M. G. Farrace, A. Rinaldi, L. Tuosto, G. Melino, and M. Piacentini
Transglutaminase Type II Is Involved in the Pathogenesis of Endotoxic Shock
J. Immunol., February 15, 2008; 180(4): 2616 - 2624.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
G. Sethi, B. Sung, and B. B. Aggarwal
Nuclear Factor-{kappa}B Activation: From Bench to Bedside
Experimental Biology and Medicine, January 1, 2008; 233(1): 21 - 31.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T.-S. Lai, Y. Liu, W. Li, and C. S. Greenberg
Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells
FASEB J, December 1, 2007; 21(14): 4131 - 4143.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Zer, G. Sachs, and J. M. Shin
Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-{alpha} signaling
Physiol Genomics, October 19, 2007; 31(2): 343 - 351.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-S. Park, J.-M. Kim, D.-S. Kim, I.-H. Kim, and S.-Y. Kim
Transglutaminase 2 Mediates Polymer Formation of I-{kappa}B{alpha} through C-terminal Glutamine Cluster
J. Biol. Chem., November 17, 2006; 281(46): 34965 - 34972.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D.-S. Kim, S.-S. Park, B.-H. Nam, I.-H. Kim, and S.-Y. Kim
Reversal of Drug Resistance in Breast Cancer Cells by Transglutaminase 2 Inhibition and Nuclear Factor-{kappa}B Inactivation.
Cancer Res., November 15, 2006; 66(22): 10936 - 10943.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. P. Mann, A. Verma, G. Sethi, B. Manavathi, H. Wang, J. Y. Fok, A. B. Kunnumakkara, R. Kumar, B. B. Aggarwal, and K. Mehta
Overexpression of Tissue Transglutaminase Leads to Constitutive Activation of Nuclear Factor-{kappa}B in Cancer Cells: Delineation of a Novel Pathway.
Cancer Res., September 1, 2006; 66(17): 8788 - 8795.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. Tong, R. M. Corrales, Z. Chen, A. L. Villarreal, C. S. De Paiva, R. Beuerman, D.-Q. Li, and S. C. Pflugfelder
Expression and Regulation of Cornified Envelope Proteins in Human Corneal Epithelium
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1938 - 1946.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. F. Liu and A. B. Malik
NF-{kappa}B activation as a pathological mechanism of septic shock and inflammation
Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L622 - L645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Mishra, A. Saleh, P. S. Espino, J. R. Davie, and L. J. Murphy
Phosphorylation of Histones by Tissue Transglutaminase
J. Biol. Chem., March 3, 2006; 281(9): 5532 - 5538.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.